Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
50,495,188
-
Number of holders
-
696
-
Total 13F shares, excl. options
-
47,053,533
-
Shares change
-
+369,397
-
Total reported value, excl. options
-
$17,719,824,151
-
Value change
-
+$122,176,357
-
Put/Call ratio
-
56%
-
Number of buys
-
300
-
Number of sells
-
-322
-
Price
-
$376.78
Significant Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q4 2021
790 filings reported holding CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share as of Q4 2021.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) has 696 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47,053,533 shares
of 50,495,188 outstanding shares and own 93.18% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5,869,125 shares), BlackRock Inc. (5,080,026 shares), FMR LLC (2,770,129 shares), STATE STREET CORP (2,030,795 shares), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (1,552,655 shares), Invesco Ltd. (1,413,044 shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (1,292,115 shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1,076,250 shares), Clearbridge Investments, LLC (1,067,784 shares), and GEODE CAPITAL MANAGEMENT, LLC (924,738 shares).
This table shows the top 696 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.